Skip to main content
Clinical Trials/ChiCTR2000031114
ChiCTR2000031114Active, not recruitingEarly Phase 1

核块下超声乳化对减少硬核白内障手术角膜内皮细胞损伤临床效果探讨

自筹1 site in 1 country246 target enrollmentStarted: April 1, 2020Last updated:

Trial Snapshot

Phase
Early Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
246
Locations
1
Primary Endpoint
角膜厚度

Study Overview

Brief Summary

评价核块下超声乳化对减小硬核白内障手术角膜损伤的临床效果。

Study Design

Study Type
干预性研究
Primary Purpose
随机平行对照
Masking
随机双盲设计,结果检查者不知道分组情况

Eligibility Criteria

Ages
50 to 80 (—)
Sex
All

Inclusion Criteria

  • 2020.3-2020.9 诊断为老年性白内障病人,按照核的硬度分级 IV-V 级,年龄 50-80 岁

Exclusion Criteria

  • 排除全身性慢性疾病,如高血压、糖尿病、肾功能不全、贫血等,排除合并有葡萄膜炎、青光眼、眼底视网膜疾病史。排除有其它内眼手术史如青光眼术后、玻璃体视网术后病史,排除角膜内皮计数低于 1200/mm2 的病例以及不愿意及不能随访者。

Arms & Interventions

1

常规白内障超声乳化吸除术

2

核块下超声乳化白内障吸除

Outcomes

Primary Outcomes

角膜厚度

角膜内皮细胞计数

视力

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
自筹

Study Sites (1)

Loading locations...

Similar Trials